J. Oosterheert

发表

External validation and update of a prognostic model to predict mortality in hospitalized adults with RSV: A retrospective Dutch cohort study

C. Naaktgeboren, L. Vos, J. Oosterheert, 2019, Journal of medical virology.

Response Adjusted for Days of Antibiotic Risk (RADAR): evaluation of a novel method to analyze antibiotic stewardship interventions

M. Bonten, M. van Smeden, J. Oosterheert, 2017, bioRxiv.

Immunomodulatory effects of macrolides during community-acquired pneumonia: a literature review.

J. Oosterheert, G. Rijkers, A. Hoepelman, 2012, The Journal of antimicrobial chemotherapy.

Management of Community-Acquired Pneumonia.

M. Bonten, J. Oosterheert, C. H. van Werkhoven, 2016, JAMA.

Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial

J. Lammers, M. Bonten, E. Buskens, 2006, BMJ : British Medical Journal.

Antibiotic treatment strategies for community-acquired pneumonia in adults.

W. Boersma, M. Bonten, J. Oosterheert, 2015, The New England journal of medicine.

Incidence and costs of hospitalized adult influenza patients in The Netherlands: a retrospective observational study

J. Oosterheert, M. Mangen, W. van der Hoek, 2020, The European Journal of Health Economics.

Narrow-spectrum antibiotics for community-acquired pneumonia in Dutch adults (CAP-PACT): a cross-sectional, stepped-wedge, cluster-randomised, non-inferiority, antimicrobial stewardship intervention trial.

W. Boersma, M. Bonten, J. Oosterheert, 2021, The Lancet. Infectious diseases.

Confounding by indication of the safety of de-escalation in community-acquired pneumonia: A simulation study embedded in a prospective cohort

M. Bonten, J. Oosterheert, P. D. van der Linden, 2019, bioRxiv.

Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalized patients with community-acquired pneumonia

M. Hulscher, J. Oosterheert, M. Emmelot‐Vonk, 2012 .

Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP

M. Hulscher, J. Oosterheert, M. Emmelot‐Vonk, 2012, European Respiratory Journal.

International classification of diseases codes showed modest sensitivity for detecting community-acquired pneumonia.

H. Leufkens, M. Bonten, R. Kaplan, 2007, Journal of clinical epidemiology.

Rapid Molecular Tests for Influenza, Respiratory Syncytial Virus, and Other Respiratory Viruses: A Systematic Review of Diagnostic Accuracy and Clinical Impact Studies

J. Reitsma, L. Vos, J. Oosterheert, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A tailored implementation strategy to reduce the duration of intravenous antibiotic treatment in community-acquired pneumonia: a controlled before-and-after study

M. Hulscher, J. Oosterheert, R. Stellato, 2014, European Journal of Clinical Microbiology & Infectious Diseases.

Cause-specific long-term mortality rates in patients recovered from community-acquired pneumonia as compared with the general Dutch population.

J. Oosterheert, A. Hoepelman, J. Prins, 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Time for first antibiotic dose is not predictive for the early clinical failure of moderate–severe community-acquired pneumonia

E. Hak, J. Oosterheert, A. Bruns, 2009, European Journal of Clinical Microbiology & Infectious Diseases.

Fluorescence in situ hybridization for detecting Coxiella burnetii in tissue samples from chronic Q fever patients.

J. Oosterheert, P. Nooijen, P. Wever, 2022, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

New trends in the prevention and management of community-acquired pneumonia.

M. Bonten, J. Oosterheert, D. Postma, 2012, The Netherlands journal of medicine.

Cost-effectiveness of antibiotic treatment strategies for community-acquired pneumonia: results from a cluster randomized cross-over trial

M. Bonten, J. Oosterheert, M. Mangen, 2017, BMC Infectious Diseases.

New clinical prediction model for early recognition of sepsis in adult primary care patients: a prospective diagnostic cohort study of development and external validation

R. Hopstaken, H. Bouma, P. Little, 2022, The British journal of general practice : the journal of the Royal College of General Practitioners.

Development of a clinical prediction rule for sepsis in primary care: protocol of the TeSD-IT study

R. Hopstaken, J. Oosterheert, A. Van den Bruel, 2020 .

Identification of patients at high risk for Clostridium difficile infection: development and validation of a risk prediction model in hospitalized patients treated with antibiotics.

M. Bonten, J. Oosterheert, R. Diepersloot, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

The immunomodulatory effects of statins in community-acquired pneumonia: a systematic review.

J. Oosterheert, D. Troeman, D. Postma, 2013, The Journal of infection.

Atypical coverage in community-acquired pneumonia after outpatient beta-lactam monotherapy.

M. Bonten, J. Oosterheert, E. M. van de Garde, 2017, Respiratory medicine.

Diagnostic, therapeutic and economic consequences of a positive urinary antigen test for Legionella spp. in patients admitted with community-acquired pneumonia: a 7-year retrospective evaluation

J. Oosterheert, A. Hoepelman, S. Thijsen, 2013, Journal of Clinical Pathology.

Long-term survival in community-acquired pneumonia caused by other bacteria than pneumococci is impaired more than in pneumococcal pneumonia: effect of underlying disease?

J. Oosterheert, A. Bruns, A. Hoepelman, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Algorithm To Determine Cost Savings of Targeting Antimicrobial Therapy Based on Results of Rapid Diagnostic Testing

M. Bonten, E. Buskens, J. Oosterheert, 2003, Journal of Clinical Microbiology.

Severe community-acquired pneumonia: whatʼs in a name?

M. Bonten, E. Hak, J. Oosterheert, 2003 .

Severe community-acquired pneumonia: what's in a name?

E. Hak, J. Oosterheert, Marc J. M. Bonten, 2003, Current opinion in infectious diseases.

Positive urinary antigen tests for Streptococcus pneumoniae in community-acquired pneumonia: a 7-year retrospective evaluation of health care cost and treatment consequences

J. Oosterheert, A. Hoepelman, S. Thijsen, 2013, European Journal of Clinical Microbiology & Infectious Diseases.

Community-acquired pneumonia requiring hospitalization: rational decision making and interpretation of guidelines

J. Oosterheert, D. Postma, C. H. van Werkhoven, 2017, Current opinion in pulmonary medicine.

Impact of different empirical antibiotic treatment regimens for community-acquired pneumonia on the emergence of Clostridium difficile.

A. Troelstra, J. Lammers, E. Kuijper, 2010, The Journal of antimicrobial chemotherapy.

Pneumonia Recovery; Discrepancies in Perspectives of the Radiologist, Physician and Patient

J. Oosterheert, B. Opmeer, J. Prins, 2009, Journal of General Internal Medicine.

Predictors for individual patient antibiotic treatment effect in hospitalized community-acquired pneumonia patients.

M. Bonten, J. Oosterheert, A. Simonetti, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial

M. Bonten, J. Oosterheert, L. V. van Elden, 2017, bioRxiv.

Predicted effects on antibiotic use following the introduction of British or North American guidelines for community-acquired pneumonia in The Netherlands.

M. Bonten, J. Oosterheert, I. Hoepelman, 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Lower respiratory tract infection in the community: associations between viral aetiology and illness course

H. Goossens, N. Zuithoff, D. Crook, 2020, Clinical Microbiology and Infection.

How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review.

M. Bonten, E. Hak, J. Oosterheert, 2003, The Journal of antimicrobial chemotherapy.

Pancreatic Stone Protein as a Biomarker for Sepsis at the Emergency Department of a Large Tertiary Hospital

J. Oosterheert, K. Kaasjager, R. Musson, 2022, Pathogens.

The High Impact of Penicillin Allergy Registration in Hospitalized Patients.

H. Gardarsdottir, M. D. de Groot, J. Oosterheert, 2016, The journal of allergy and clinical immunology. In practice.

Axial light loss of monocytes as a readily available prognostic biomarker in patients with suspected infection at the emergency department

M. D. de Groot, J. Oosterheert, S. Haitjema, 2022, PloS one.

Predicting community-acquired pneumonia etiology.

M. Bonten, J. Oosterheert, D. Postma, 2013, Chest.

Case report: Coxiella burnetii vascular infection and lymphoma in the Netherlands

D. Raoult, J. Oosterheert, P. Nooijen, 2017, Infection.

The choice of empirical antibiotic treatment for patients with clinically suspected community-acquired pneumonia (CAP) who are admitted to non–intensive care unit (ICU) hospital wards is complicated by the limited availability of evidence. We compared strategies of empirical treatment (allowing devi

W. Boersma, M. Bonten, J. Oosterheert, 2015 .

Cost-effectiveness of Screening Program for Chronic Q Fever, the Netherlands

J. Oosterheert, W. van der Hoek, P. D. de Boer, 2020, Emerging infectious diseases.

Seroprevalence of Coxiella burnetii antibodies and chronic Q fever among post-mortal and living donors of tissues and cells from 2010 to 2015 in the Netherlands

J. Oosterheert, M. V. van Wijk, B. Hogema, 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Chronic Q Fever Diagnosis—Consensus Guideline versus Expert Opinion

J. Oosterheert, M. V. van Kasteren, T. Sprong, 2015, Emerging infectious diseases.

Chronic Q Fever in the Netherlands 5 Years after the Start of the Q Fever Epidemic: Results from the Dutch Chronic Q Fever Database

J. Oosterheert, M. V. van Kasteren, N. Renders, 2014, Journal of Clinical Microbiology.

Defining chronic Q fever: a matter of debate.

M. Koopmans, J. Oosterheert, M. V. van Kasteren, 2012, The Journal of infection.

Identification of Risk Factors for Chronic Q Fever, the Netherlands

C. A. Groot, J. Oosterheert, P. Lestrade, 2012, Emerging infectious diseases.

Chronic Q fever: review of the literature and a proposal of new diagnostic criteria.

M. Koopmans, J. Oosterheert, M. V. van Kasteren, 2012, The Journal of infection.

Chronic Q Fever-Related Dual-Pathogen Endocarditis: Case Series of Three Patients

J. Oosterheert, P. Lestrade, N. Renders, 2011, Journal of Clinical Microbiology.

Delayed Diagnosis of Chronic Q Fever and Cardiac Valve Surgery

J. Oosterheert, N. Renders, P. Wever, 2013, Emerging infectious diseases.

A semi-supervised decision support system to facilitate antibiotic stewardship for urinary tract infections

D. Thierens, J. Oosterheert, S. Vries, 2022, Comput. Biol. Medicine.

Treatment restrictions and empirical antibiotic treatment of community-acquired pneumonia in elderly patients.

M. Bonten, J. Oosterheert, D. Postma, 2016, The Netherlands journal of medicine.

Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.

A. Osterhaus, C. Boucher, M. Koopmans, 2011, Antiviral research.

Two cases of Plasmodium falciparum malaria in the Netherlands without recent travel to a malaria-endemic country.

J. A. Kaan, E. Scholte, J. Oosterheert, 2013, The American journal of tropical medicine and hygiene.

Treatment of Chronic Q Fever: Clinical Efficacy and Toxicity of Antibiotic Regimens

J. Oosterheert, P. Wever, A. Hoepelman, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antibiotic treatment for 6 days versus 12 days in patients with severe cellulitis: a multicentre randomised, double-blind, placebo-controlled, non-inferiority trial.

P. D. de Vries, J. Oosterheert, W. Wiersinga, 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

The incidence, mortality and renal outcomes of acute kidney injury in patients with suspected infection at the emergency department

J. Oosterheert, G. Ocak, S. Haitjema, 2021, PloS one.

As Nossas Leituras Our Readings

E. Hak, J. Oosterheert, A. Hoepelman, 2009 .

A highly virulent variant of HIV-1 circulating in the Netherlands

Michael J. Rausch, H. Jessen, A. Trkola, 2022, Science.

Diagnosis and treatment of tuberculous uveitis in a low endemic setting.

A. Vos, J. Oosterheert, M. Wassenberg, 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

High epidemic burden of RSV disease coinciding with genetic alterations causing amino acid substitutions in the RSV G-protein during the 2016/2017 season in The Netherlands.

L. Vos, J. Oosterheert, L. Bont, 2019, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Molecular and Serological Intraocular Fluid Analysis of Coxiella burnetii-seropositive Patients with Concurrent Idiopathic Uveitis

J. Oosterheert, A. Rothova, J. Dekkers, 2016, Ocular immunology and inflammation.

Frequent Detection of Human Coronaviruses in Clinical Specimens from Patients with Respiratory Tract Infection by Use of a Novel Real-Time Reverse-Transcriptase Polymerase Chain Reaction

J. Oosterheert, P. Schipper, F. V. van Alphen, 2004, The Journal of infectious diseases.

The Skin Microbiota in Patients Hospitalized for Cellulitis and Association With Outcome

P. Savelkoul, F. Hugenholtz, P. D. de Vries, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The effect of measuring serum doxycycline concentrations on clinical outcomes during treatment of chronic Q fever

J. Oosterheert, P. Wever, A. Hoepelman, 2018, The Journal of antimicrobial chemotherapy.

Antibiotic prophylaxis for high-risk patients with acute Q Fever: no definitive answers yet.

J. Oosterheert, P. Wever, C. Bleeker‐Rovers, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Screening for Coxiella burnetii seroprevalence in chronic Q fever high-risk groups reveals the magnitude of the Dutch Q fever outbreak

J. Oosterheert, P. Lestrade, N. Renders, 2012, Epidemiology and Infection.

Biomarkers define the clinical response to dexamethasone in community-acquired pneumonia.

W. Bos, H. Endeman, J. Grutters, 2012, The Journal of infection.

Interventions for rapid recognition and treatment of sepsis in the emergency department - A narrative review.

J. Oosterheert, K. Thursky, K. Kaasjager, 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Evaluating the evidence for the implementation of C-reactive protein measurement in adult patients with suspected lower respiratory tract infection in primary care: a systematic review.

J. Oosterheert, A. Hoepelman, V. van der Meer, 2012, Family practice.

Chronic Q fever-related complications and mortality: data from a nationwide cohort.

J. Oosterheert, W. van der Hoek, P. Wever, 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[The increase in pneumonia-related morbidity and mortality among adults in the Netherlands and possible explanations for it].

J. Lammers, M. Bonten, E. Hak, 2005, Nederlands tijdschrift voor geneeskunde.

The prognostic value of red blood cell distribution width in patients with suspected infection in the emergency department

J. Oosterheert, P. Oomen, K. Kaasjager, 2019, BMC Emergency Medicine.

Prevalence of Chronic Q Fever in Patients with a History of Cardiac Valve Surgery in an Area Where Coxiella burnetii Is Epidemic

J. Oosterheert, P. Lestrade, N. Renders, 2012, Clinical and Vaccine Immunology.

No Value for Routine Serologic Screening for Borrelia burgdorferi in Patients With Uveitis in the Netherlands.

J. Oosterheert, N. H. ten Dam-van Loon, J. Ossewaarde-van Norel, 2016, American journal of ophthalmology.

Corneal Graft Rejection Complicated by Paracoccus yeei Infection in a Patient Who Had Undergone a Penetrating Keratoplasty

J. Oosterheert, M. Kanis, C. H. Boel, 2009, Journal of Clinical Microbiology.

Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia.

E. Hak, J. Oosterheert, A. Hoepelman, 2009, Revista portuguesa de pneumologia.

High Treatment Uptake in Human Immunodeficiency Virus/Hepatitis C Virus–Coinfected Patients After Unrestricted Access to Direct-Acting Antivirals in the Netherlands

B. Berkhout, M. Wegdam, R. Meijering, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

No increased risk of mature B-cell non-Hodgkin lymphoma after Q fever detected: results from a 16-year ecological analysis of the Dutch population incorporating the 2007–2010 Q fever outbreak

M. Bonten, J. Oosterheert, W. van der Hoek, 2022, International journal of epidemiology.

Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia

E. Hak, J. Oosterheert, A. Hoepelman, 2008, European Respiratory Journal.

The prognostic value of serological titers for clinical outcomes during treatment and follow-up of patients with chronic Q fever.

J. Oosterheert, P. Wever, A. Hoepelman, 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Skin lesions in a diabetic patient: what is your diagnosis?

J. Oosterheert, H. Kaasjager, M. Dankbaar, 2019 .

A machine learning approach using endpoint adjudication committee labels for the identification of sepsis predictors at the emergency department

J. Oosterheert, S. Haitjema, W. V. van Solinge, 2022, BMC emergency medicine.

Coxiella burnetii infection (Q fever) in rheumatoid arthritis patients with and without anti-TNFα therapy

P. van Riel, J. Oosterheert, M. van Deuren, 2014, Annals of the rheumatic diseases.

Chronic Q fever: patient and treatment-related factors influencing long-term quality of life

J. Oosterheert, P. Wever, C. V. van Jaarsveld, 2018, QJM : monthly journal of the Association of Physicians.

Code status documentation at admission in COVID-19 patients: a descriptive cohort study

J. Oosterheert, K. Kaasjager, F. van den Bos, 2021, BMJ Open.

Impact of Rapid Detection of Viral and Atypical Bacterial Pathogens by Real-Time Polymerase Chain Reaction for Patients with Lower Respiratory Tract Infection

M. Bonten, E. Hak, J. Oosterheert, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Predictors of Bacteraemia in Patients with Suspected Community-Acquired Pneumonia

M. Bonten, J. Oosterheert, D. Postma, 2015, PloS one.

A tailored implementation strategy to reduce the duration of intravenous antibiotic treatment in community-acquired pneumonia: a controlled before-and-after study

M. Hulscher, J. Oosterheert, R. Stellato, 2014, European Journal of Clinical Microbiology & Infectious Diseases.

Antibiotic treatment of moderate-severe community-acquired pneumonia: design and rationale of a multicentre cluster-randomised cross-over trial.

M. Bonten, J. Oosterheert, D. Postma, 2014, The Netherlands journal of medicine.

Positive urinary antigen tests for Streptococcus pneumoniae in community-acquired pneumonia: a 7-year retrospective evaluation of health care cost and treatment consequences

J. Oosterheert, A. Hoepelman, S. Thijsen, 2013, European Journal of Clinical Microbiology & Infectious Diseases.

Community-Acquired Pneumonia—Back to Basics

M. Bonten, J. Oosterheert, 2008, Antibiotic Policies: Fighting Resistance.

Patterns of resolution of chest radiograph abnormalities in adults hospitalized with severe community-acquired pneumonia.

M. Prokop, J. Lammers, E. Hak, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Differences in Documented and Actual Medication Administration Time in the Emergency Department: A Prospective, Observational, Time-Motion Study.

J. Oosterheert, L. Schoonhoven, K. Kaasjager, 2021, Journal of emergency nursing.

Development and external validation of a new clinical prediction model for early recognition of sepsis in adult patients in primary care: a diagnostic study

R. Hopstaken, H. Bouma, P. Little, 2022, British Journal of General Practice.

Retrospective study on the possible existence of a treatment paradox in sepsis scores in the emergency department

J. Reitsma, J. Oosterheert, K. Kaasjager, 2021, BMJ Open.

Community-Onset Staphylococcus aureus Lower Respiratory Tract Infections: A Young Man’s Foe?

J. Oosterheert, A. Hoepelman, 2013 .

Antibiotic misuse in respiratory tract infections in children and adults—a prospective, multicentre study (TAILORED Treatment)

E. Eden, I. Braverman, J. Oosterheert, 2019, European Journal of Clinical Microbiology & Infectious Diseases.

Blue rubber bleb nevus syndrome co-existing with celiac disease.

J. Oosterheert, M. Bousema, J. Lagendijk, 2006, The Netherlands journal of medicine.

Bacteremic complications of intravascular catheter tip colonization with Gram-negative micro-organisms in patients without preceding bacteremia

J. Oosterheert, E. Peters, I. Hoepelman, 2011, European Journal of Clinical Microbiology & Infectious Diseases.

Candidemic complications in patients with intravascular catheters colonized with Candida species: an indication for preemptive antifungal therapy?

D. D. de Lange, J. Oosterheert, A. Hoepelman, 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Coxiella burnetii in non-Hodgkin lymphoma tissue samples: Innocent until proven otherwise?

J. Oosterheert, P. Nooijen, P. Wever, 2019, Immunobiology.

Exposure to Coxiella burnetii and risk of non-Hodgkin lymphoma: a retrospective population-based analysis in the Netherlands.

M. Bonten, J. Oosterheert, W. van der Hoek, 2018, The Lancet. Haematology.

Bacteremic complications of intravascular catheter tip colonization with Gram-negative micro-organisms in patients without preceding bacteremia

J. Oosterheert, E. Peters, I. Hoepelman, 2011, European Journal of Clinical Microbiology & Infectious Diseases.

‘Chronic Q fever-related complications and mortality: data from a nationwide cohort’ – Author’s reply

J. Oosterheert, S. E. van Roeden, Peter C. Wever, 2019, Clinical Microbiology and Infection.

No Influence of Previous Coxiella burnetii Infection on ICU Admission and Mortality in Emergency Department Patients Infected with SARS-CoV-2

J. Oosterheert, P. Wever, A. Hoepelman, 2022, Journal of clinical medicine.

Primary and secondary arterial fistulas during chronic Q fever

G. D. de Borst, J. Oosterheert, N. Renders, 2018, Journal of Vascular Surgery.

Acute Q fever related in-hospital mortality in the Netherlands.

C. A. Groot, J. Oosterheert, N. Arents, 2010, The Netherlands journal of medicine.

High levels of serum prostate‐specific antigen due to PSA producing follicular non‐Hodgkin’s lymphoma

J. Oosterheert, P. Vos, S. Wittebol, 2007, European journal of haematology.

More targeted use of oseltamivir and in-hospital isolation facilities after implementation of a multifaceted strategy including a rapid molecular diagnostic panel for respiratory viruses in immunocompromised adult patients

L. Vos, J. Oosterheert, A. Hoepelman, 2019, Journal of Clinical Virology.

Use of the moving epidemic method (MEM) to assess national surveillance data for respiratory syncytial virus (RSV) in the Netherlands, 2005 to 2017

J. Lozano, T. Vega, L. Vos, 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

The diagnostic value of nasal microbiota and clinical parameters in a multi-parametric prediction model to differentiate bacterial versus viral infections in lower respiratory tract infections

S. A. Boers, Saskia D. Hiltemann, E. Eden, 2022, PloS one.

Obstructive jaundice in von Recklinghausen’s disease • Histoplasma capsulatum in chronic lymphocytic leukaemia . Exposure to calcium and phosphate in kidney disease Euthyroid enlargement of the thyroid gland: what is your diagnosis?

C. A. Groot, M. Heijer, P. Speelman, 2010 .

Microbiological Challenges in the Diagnosis of Chronic Q Fever

C. A. Groot, J. Oosterheert, M. V. van Kasteren, 2012, Clinical and Vaccine Immunology.

Syndromic sample-to-result PCR testing for respiratory infections in adult patients.

L. Vos, J. Oosterheert, A. Hoepelman, 2018, Netherlands Journal of Medicine.

Testing for viral infections in severe lower respiratory tract infections; the unpredictable effects of diagnostic certainty.

L. Vos, J. Oosterheert, 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Hematological Ratios Are Associated with Acute Kidney Injury and Mortality in Patients That Present with Suspected Infection at the Emergency Department

J. Oosterheert, G. Ocak, S. Haitjema, 2022, Journal of clinical medicine.

Single nucleotide polymorphism (SNP) rs3751143 in P2RX7 is associated with therapy failure in chronic Q fever while rs7125062 in MMP1 is associated with fewer complications.

J. Oosterheert, M. van Deuren, P. Wever, 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Effectiveness of oseltamivir in reduction of complications and 30-day mortality in severe seasonal influenza infection.

J. Oosterheert, J. V. van Dissel, G. Groeneveld, 2020, International journal of antimicrobial agents.

Diagnosis and treatment of community-acquired lower respiratory tract infections : Strategies for efficient management

J. Oosterheert, 2005 .

Development of a clinical prediction rule for sepsis in primary care: protocol for the TeSD-IT study

R. Hopstaken, J. Oosterheert, A. Van den Bruel, 2020, Diagnostic and Prognostic Research.

Response Adjusted for Days of Antibiotic Risk (RADAR): evaluation of a novel method to compare strategies to optimize antibiotic use.

M. Bonten, M. van Smeden, J. Oosterheert, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Bacillus Calmette-Gu (cid:1) erin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities: a randomized controlled trial

M. A. van den Bosch, J. H. van de Wijgert, W. Boersma, 2022 .

Rapid Tests for Common Respiratory Viruses.

L. Vos, J. Oosterheert, A. Hoepelman, 2017, Clinical Infectious Diseases.

Antibiotic misuse in respiratory tract infections in children and adults—a prospective, multicentre study (TAILORED Treatment)

Andrew P. Stubbs, E. Eden, I. Braverman, 2019, European Journal of Clinical Microbiology & Infectious Diseases.

The role of vitamin D supplementation in the risk of developing pneumonia: three independent case–control studies

M. D. de Groot, W. Bos, J. Oosterheert, 2013, Thorax.

Impact of different empirical antibiotic treatment regimens for community-acquired pneumonia on the emergence of Clostridium difficile.

A. Troelstra, J. Lammers, E. Kuijper, 2010, The Journal of antimicrobial chemotherapy.

Evaluating the evidence for the implementation of C-reactive protein measurement in adult patients with suspected lower respiratory tract infection in primary care: a systematic review.

J. Oosterheert, A. Hoepelman, V. van der Meer, 2012, Family practice.

Prognostic factors for early clinical failure in patients with severe community-acquired pneumonia.

J. Oosterheert, I. Hoepelman, M. Hoogewerf, 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Antimicrobials for pulmonary infections

J. Oosterheert, A. Hoepelman, 2006 .